Sigyn Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $99.2K | $84.4K |
| FY2021 | — | $-264.6K | $341.0K |
| FY2022 | $2.3M | $-1.9M | $8.4K |
| FY2023 | $2.5M | $-3.4M | $11.7K |
| FY2024 | $2.0M | $-4.5M | $12.1K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $99.2K | $84.4K |
| FY2021 | — | $-264.6K | $341.0K |
| FY2022 | $2.3M | $-1.9M | $8.4K |
| FY2023 | $2.5M | $-3.4M | $11.7K |
| FY2024 | $2.0M | $-4.5M | $12.1K |